TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Scanbio Ingredients AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
80,012
|
102,587
|
71,310 |
| Financial expenses |
23,931
|
22,896
|
10,540 |
| Earnings before taxes |
5,764
|
9,784
|
10,079 |
| Total assets |
78,723
|
61,900
|
51,073 |
| Current assets |
60,876
|
46,863
|
39,142 |
| Current liabilities |
49,316
|
28,993
|
17,589 |
| Equity capital |
28,932
|
32,504
|
33,418 |
| - share capital |
20,091
|
21,173
|
22,610 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.8%
|
52.5%
|
65.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
9.5%
|
14.1% |
| Return on assets (ROA) |
37.7%
|
52.8%
|
40.4% |
| Current ratio |
123.4%
|
161.6%
|
222.5% |
| Return on equity (ROE) |
19.9%
|
30.1%
|
30.2% |
| Change turnover |
-17,332
|
35,808
|
12,151 |
| Change turnover % |
-18%
|
54%
|
21% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.